|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.790 CNY | +1.27% |
|
-3.62% | -6.45% |
| 06-11 | Jointown Pharma Issues 1 Billion Yuan in Asset-Backed Securities | MT |
| 06-03 | Jointown Pharmaceutical Unit Gets Nod to Market Allergy Symptoms Treatment | MT |
| Market Cap | 23.89B 3.53B 3.05B 2.81B 2.63B 4.93B 335B 5B 33.17B 12.93B 163B 13.25B 12.96B 565B | P/E Ratio 2026 * |
10.9x | P/E Ratio 2027 * | 9.29x |
|---|---|---|---|---|---|
| Enterprise Value | 19.83B 2.93B 2.53B 2.33B 2.18B 4.09B 279B 4.15B 27.54B 10.74B 136B 11B 10.76B 469B | EV / Sales 2026 * |
0.12x | EV / Sales 2027 * | 0.1x |
| Free-Float |
43.03% | Yield 2026 * |
4.04% | Yield 2027 * | 4.65% |
| 1 day | +1.27% | ||
| 1 week | -3.62% | ||
| Current month | -0.21% | ||
| 1 month | -5.52% | ||
| 3 months | -9.79% | ||
| 6 months | -5.71% | ||
| Current year | -6.45% |
| 1 week | 4.66 |  | 4.85 |
| 1 month | 4.63 | | 5.02 |
| Current year | 4.63 | | 5.84 |
| 1 year | 4.63 | | 5.84 |
| 3 years | 4.35 | | 6.94 |
| 5 years | 3.97 | | 6.94 |
| 10 years | 3.97 | | 8.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei He
CEO | Chief Executive Officer | 40 | 2022-04-22 |
Xiao Yi Xia
DFI | Director of Finance/CFO | 48 | 2023-11-14 |
Xi Zhang
IRC | Investor Relations Contact | - | 2022-04-22 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhao Nian Liu
BRD | Director/Board Member | 66 | 2008-11-15 |
Deng Pan Liu
BRD | Director/Board Member | 48 | 2020-11-04 |
Yi Hua Gong
BRD | Director/Board Member | 48 | 2012-06-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.27% | -3.62% | -11.95% | -14.53% | 3.53B | |
| -0.40% | +1.08% | +7.67% | +97.49% | 94.25B | |
| +1.22% | +8.82% | +38.68% | +154.32% | 52.43B | |
| -1.86% | -9.59% | -18.77% | +214.29% | 21.42B | |
| +0.62% | +0.49% | -10.95% | -25.32% | 8.13B | |
| -0.07% | +2.43% | -34.66% | -28.05% | 7.54B | |
| +1.19% | -1.22% | -11.46% | -36.80% | 6.77B | |
| -2.80% | -2.46% | +11.48% | +21.79% | 6.49B | |
| +0.30% | +1.01% | -0.93% | +17.66% | 5.32B | |
| -1.64% | -1.29% | +11.36% | +12.16% | 3.37B | |
| Average | -0.22% | +0.71% | -1.95% | +41.30% | 20.92B | |
| Weighted average by Cap. | -0.09% | +3.38% | +9.49% | +102.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 170B 25.15B 21.72B 20.02B 18.74B 35.12B 2,391B 35.66B 236B 92.16B 1,164B 94.39B 92.38B 4,029B | 179B 26.48B 22.87B 21.07B 19.72B 36.97B 2,517B 37.54B 249B 97.01B 1,225B 99.37B 97.25B 4,241B |
| Net income | 2.22B 328M 283M 261M 244M 457M 31.13B 464M 3.08B 1.2B 15.15B 1.23B 1.2B 52.46B | 2.6B 384M 332M 306M 286M 537M 36.53B 545M 3.61B 1.41B 17.78B 1.44B 1.41B 61.57B |
| Net Debt | -4.06B -599M -518M -477M -446M -837M -56.96B -850M -5.63B -2.2B -27.73B -2.25B -2.2B -96B | -5.32B -786M -679M -625M -585M -1.1B -74.69B -1.11B -7.38B -2.88B -36.36B -2.95B -2.89B -126B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 4.790 ¥ | +1.27% | 36,240,300 |
| 26-06-11 | 4.730 ¥ | +0.21% | 27,393,060 |
| 26-06-10 | 4.720 ¥ | -0.84% | 27,974,230 |
| 26-06-09 | 4.760 ¥ | -0.63% | 22,192,236 |
| 26-06-08 | 4.790 ¥ | -3.62% | 37,964,024 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600998 Stock
Select your edition
All financial news and data tailored to specific country editions
